The current paradigm states that inflammatory pain passively resolves following the cessation of the inflammatory insult. Yet, in a substantial proportion of patients with inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, spontaneous or treatment-induced resolution of inflammation is not sufficient to resolve pain, resulting in chronic pain 1-5 . Mechanistic insight as how inflammatory pain is resolved is lacking.
Main text
Pain and pain hypersensitivity (hyperalgesia) are functional features of inflammation that serve to protect the tissue from further damage. At the site of inflammation, immune cells and inflammatory mediators, such as IL-1β, TNF, and bradykinin, sensitize and activate sensory neurons, which cause pain and hyperalgesia 6, 7 . While the initiation of inflammatory pain is relatively well understood 8, 9 , the mechanisms of inflammatory pain resolution are less well characterized. We here set out to better understand the resolution of inflammatory pain and the role of immune cells in this process.
We injected carrageenan into the hind paw of mice (intraplantar; i.pl.) as a model for 4F-H). These data show that monocytes are essential to resolve inflammatory pain and sufficient when specifically grafted into the DRG.
Macrophages that reside in peripheral nerve tissue are different from microglia and or nonnervous residing macrophages 13, 14 and can be programmed by sensory neurons 15 . We determined whether monocytes/macrophages that infiltrate the DRG had an inflammatory ('M1') -or resolution ('M2')-like phenotype. At day 3, the number of CD206 + M2-like or tissue-repair macrophages 16, 17 was increased in the DRG, whereas the number of iNOS + M1-like or 19 . Neurons have a very high metabolic demand 20 . We previously demonstrated that a deficiency in mitochondrial function in sensory neurons prevents the resolution of inflammatory pain 12 . Moreover, in chronic pain neuronal mitochondrial functions, such as OxPhos and Ca 2+ buffering, are impaired 21, 22 . Indeed, oxygen consumption in DRG neurons was reduced during the peak of inflammatory pain and resolved at day 3 (Supplemental data fig. 5B ). Therefore, we posited that to resolve inflammatory pain, sensory neurons have to re-establish OxPhos by restoring a functional mitochondrial pool. Given that after ischemic stroke neurons can take up mitochondria released by adjacent astrocytes 23 , we hypothesized that during pain resolution monocytes/macrophages aid neurons by supplying new mitochondria.
We stained mitochondria from macrophages with MitoTracker Deep Red (MTDR) that binds covalently to mitochondrial proteins 24 We hypothesized that the mitochondria-containing vesicles released by macrophages were sufficient to resolve pain. Indeed, i.t. administration of mitochondria-containing extracellular vesicles isolated from macrophage supernatant rapidly but transiently resolved inflammatory hyperalgesia in MM dtr mice (Fig. 2D ). However, injection of sonicated extracellular vesicles did not affect hyperalgesia. Taken together, this suggests that functional mitochondria, but not their individual components, are sufficient to resolve pain. Furthermore, monocytes that have For efficient transfer of mitochondria, we hypothesized that docking of extracellular vesicles to sensory neurons requires receptor-ligand interactions. Macrophages, predominantly those with an M2 phenotype 27 , and macrophages-derived extracellular vesicles expressed CD200R ( Fig   Supplemental data fig. 7A ), while neurons are known to express its ligand CD200 (ref. 28 ). In line with this reasoning, Cd200r -/mice completely failed to resolve inflammatory hyperalgesia, which persisted for at least 2 weeks ( Fig. 3A and Supplemental data fig. 9A ). Place-preference conditioning with the fast-working analgesic gabapentin 29 We found no evidence for a defect in mitochondrial respiration or vesicle release in Cd200r -/macrophages (Supplemental data figs. 10A-C) and Cd200r -/macrophages were normal in their capacity to migrate into the DRG and had a similar phenotype to WT mice (Supplemental data figs. 10D-H). This suggested instead that there was a defect in mitochondrial transfer between Cd200r -/macrophages and neurons. MTDR transferred normally from intrathecally injected MTDR-labelled macrophages to neurons from Cd200r -/mice (Fig. 3C) . In contrast, Cd200r -/macrophages failed to transfer MTDR-labelled mitochondria to sensory neurons of Cd200r -/mice ( Fig. 3C ) and extracellular vesicles isolated from Cd200r -/macrophage culture supernatant did not resolve inflammatory hyperalgesia in MM dtr mice ( Fig. 3D; supplemental data fig. 11 ).
Thus, CD200R expression on monocytes/macrophages and their mitochondria containing extracellular vesicles is required for transfer of mitochondria to sensory neurons and for the resolution of inflammatory pain. CD200 is the best-known ligand for CD200R and in inflammatory models, such as arthritis, Cd200 -/and Cd200r -/mice have a similar phenotype 30, 31 . However, in sharp contrast to Cd200r -/mice, Cd200 -/mice completely resolved inflammatory pain with similar kinetics to WT mice ( Fig. 4A; supplemental data fig. 12A ). This suggests the involvement of an alternative CD200R ligand. In 2016, iSec1/Gm609 was described as a CD200R ligand expressed specifically in the gut 32 . We found that iSec1/Gm609 mRNA is expressed in DRG along with CD200 fig. 12F ). In Cd200 -/mice, i.t. injections of iSec1/Gm609-ASO completely prevented the resolution of hyperalgesia ( Fig. 4C; supplemental data fig. 12G ). Next, we injected Herpes Simplex Virus (HSV) i.pl. to specifically target sensory neurons innervating that area 12 .
Expression of iSec1/gm609 (HSV-iSec1) that was mutated to resist ASO treatment (Supplemental data fig. 12H ) in sensory neurons completely rescued the ability of iSec1/Gm609-ASO treated CD200 -/mice to resolve pain, while an empty vector (HSV-e) did not ( Fig. 4D ; Supplemental data fig. 12I ). We conclude that monocyte/macrophage expression of CD200R and sensory neuron expression of its ligand iSec1 are required for the transfer of macrophage-derived mitochondria to sensory neurons in vivo to resolve inflammatory pain.
Discussion
We identified a previously unappreciated role for macrophages which transfer mitochondria to somata of sensory neurons to resolve inflammatory pain. Previous studies showed that tissueresident cells can transfer mitochondria 23, 34 . We now show that non-tissue resident monocytes are recruited to the DRG, acquire a M2/tissue-repair like phenotype and transfer mitochondria to sensory neurons via a CD200R:iSec1 interaction in order to resolve pain. In contrast to M2 macrophages, inflammatory M1 macrophages induced pain. Thus, a DRG-milieu that skews local macrophages towards a M1 phenotype could contribute to the development of chronic pain [35] [36] [37] [38] .
CD200 has long been thought of as the only ligand for CD200R. Although previous studies implicated CD200 as a checkpoint for microglia cell activation in neuropathic pain 39, 40 , we show that Cd200 -/mice fully resolve inflammatory pain. Furthermore, we found that iSec1/gm609 is expressed in DRG neurons and we demonstrated that sensory neuron-iSec1 is required to resolve inflammatory pain. Of note, iSec1/gm609 knockdown did have a greater effect on pain resolution in Cd200 -/mice than in WT mice, suggesting that the function of these ligands is partially redundant.
Various chronic pain states, such as chemotherapy-induced pain and neuropathic pain caused by trauma or diabetes, are associated with mitochondrial defects [41] [42] [43] [44] . We show here that oxidative phosphorylation is reduced during the peak of transient inflammatory pain but is restored when inflammatory hyperalgesia resolves. Hence, we postulate that resolution of inflammatory pain requires the restoration of mitochondrial homeostasis in sensory neurons and that DRG macrophages facilitate this process. Given that the injection of isolated extracellular vesicles only transiently resolves pain, a more durable resolution of pain requires a prolonged flux of mitochondria and/or additional signals from intact macrophages. These mitochondria could replace mitochondria in neurons that have incurred mitochondrial damage. Future work should assess how exactly neuronal mitochondrial homeostasis is restored by macrophagederived mitochondria.
Why would sensory neurons require external help to restore the integrity of their mitochondrial network? Sensory neurons face unique challenges in maintaining a functional mitochondrial network because of their exceptional architecture and their intense demand for energy to support energetically expensive processes such as resting potentials, firing action potentials and calcium signalling 20 . Stressed neurons, e.g. during inflammatory pain, turn to anabolic metabolism 45 . In the face of this high energy demand during stress, an energy consuming process such as rebuilding the mitochondrial network is difficult to support.
Moreover, maintaining an excess mitochondrial pool that is capable of handing the stress of inflammatory pain, would come at a high fitness cost because it would require more energy intake for the organism. Thus, we propose that dispensable monocytes/macrophages supply mitochondria to stressed indispensable neurons.
Together, our data show that pain is actively resolved by an interaction between the immune and neuronal systems that is separate from the cessation of inflammation within the peripheral tissue. Novel therapeutic strategies to resolve chronic pain may focus on the restoration of mitochondrial homeostasis in neurons or on enhancing the transfer of mitochondria from macrophages 46 . Competing interests: Authors declare no competing interests.
Data and materials availability: All data is available in the manuscript or supplementary materials. Raw data and materials will be made available upon reasonable request. Some materials used in this manuscript are subject to Material Transfer Agreement (MTA).
Supplementary Materials:

Materials and Methods
Figures S1-S12
Movies S1-S2 
Figure Legends
